Top 5 Most Viewed Conference Video Interviews of 2023
Applied Clinical Trials sat down on-site with many KOLs at some of industry's largest gatherings in 2023 including SCOPE, DIA, and DPHARM.
Below is a list of the most viewed video interviews from Applied Clinical Trials' on-site conference coverage in 2023.
1. DIA 2023: Giving Patients More Power in Decision Making
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jean Sposaro, program lead, TransCelerate BioPharma, and director, global drug development operations industry collaborations, Bristol Myers Squibb discusses initiatives that TransCelerate is currently working on to empower patients.
Watch the interview here.
2. DPHARM 2023: Vulcan FHIR Accelerator
In an interview at the 2023 DPHARM conference with ACT editor, Andy Studna, Amy Cramer, steering committee board co-chair, HL7 FHIR Accelerator Vulcan gives an overview of Vulcan and how it is working with the global research community to solve challenges in clinical trials.
Watch the interview here.
3. DIA 2023: Keeping Patients Informed
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jean Sposaro, program lead, TransCelerate BioPharma, and director, global drug development operations industry collaborations, Bristol Myers Squibb discusses riaising awareness about clinical trials and increasing the public's trust in them.
Watch the interview here.
4. DIA 2023: Understanding eConsent
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Hilde Vanaken, PhD, head, European Forum GCP (EFGCP) eConsent Initiative, and head, TCS Industry Leaders discusses what eConsent is all about and common misunderstandings surrounding it. She also touches on an article she authored for Applied Clinical Trials on eConsent which can be found here.
Watch the interview here.
5. SCOPE Europe 2023: Integrating eCOAs and DHTs
In an interview at SCOPE Europe 2023 with Applied Clinical Trials Editor, Andy Studna, Tony Mikulaschek, VP, eCOA, IQVIA Technologies discusses how eCOAs are being applied to clinical trials.
Watch the interview here.
Industry Assessment of Risk-Based Quality Management Emphasizes Value of Adoption
April 4th 2024A study conducted by the Tufts CSDD in collaboration with CluePoints and PwC revealed that slightly more than half of sponsors and contract research organizations have adopted risk-based quality management approaches.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.
